Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

The Operational Foundations That Characterize Regulatory Leaders
Holding individuals and teams explicitly accountable for data accuracy and quality might seem straightforward, but it is difficult to sustain in practice. read more
Rethinking the Architecture of Adverse Event Processing
Deploying AI agents to handle data collection, coding, medical review, and quality-checking makes signal management autonomous at the processing stage. read more
An Interview with Rod Ketner, PhD
Sponsors sometimes optimize too narrowly for the next milestone instead of the full development path. A formulation may be sufficient for an early study but still be poorly positioned for robust scale-up, transfer, or validation. That’s where delays and added costs show up. read more
Patient-Centric Drug Delivery
Across modalities and markets, patient-centric drug delivery is converging on three themes: self-administration at home, integration of drug delivery device platforms earlier in clinical trials, and alignment of formulations with device and human factors requirements. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

LGM Pharma Acquires Sannova Analytical to Expand Testing Services
Thursday, October 22, 2026
LGM Pharma has acquired Sannova Analytical, a contract research laboratory in Somerset, New Jersey, adding bioanalytical services and specialized ... read more
Medpace Revenue Rises 8.5%; Board Approves $1 Billion Buyback
Thursday, October 22, 2026
Medpace reported third-quarter revenue of $716 million, up 8.5% from a year earlier, while net income increased to $137.5 million from $111.1 million.... read more
Zylidac, Prolific Partner on Light-Controlled Biologics Manufacturing
Wednesday, October 21, 2026
Zylidac Bio and Prolific Machines have partnered to move Prolific’s light-controlled protein production technology from laboratory development toward ... read more
Touchlight Names Downie Interim CEO as Fallen Steps Down
Wednesday, October 21, 2026
Touchlight has appointed Will Downie as interim chief executive officer, replacing Karen Fallen, who is stepping down after leading the company since ... read more
Kindeva Wins Nerve Agent Autoinjector Contract Worth Up to $226 Million
Tuesday, October 20, 2026
Kindeva’s Meridian Medical Technologies division has received a Defense Logistics Agency contract worth up to $226 million to supply nerve agent ... read more